Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 205.63

+1.0%

11:29 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (28652)	4/4/1999 11:23:00 PM
From: Spekulatius	Read Replies (1) of 32384

Thanks for your response.I found the link to be extremely helpful. I indeed found some papers regarding RFS2000,conducted from the Stehlin Institute. It will be interesting to see the first sales numbers for Panretin and Ontak. Panretin may have an advantage over Ontak and Nipent, since its an orally administered drug. I still see the Seragen acquisition as wasted money.the fact that 500M$ have been spend in research does not mean anything - only the marginal Ontak drug came out of Sereagen research adnI am not aware that Seragen research projects are continued by LGND. LGND has enough trouble to fund its own pipeline.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next